ArticleFrontiers in immunology2025

Reduced hemolytic complement activity in the classical pathway (CH50) is a risk factor for poor clinical outcomes of patients with infections: a retrospective analysis of health insurance claims in Japan.

Hiroyuki Koami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.